Volume 20, 2016 Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
PreScription: Starting Year 20!
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 4
|
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Choo Winnie
|
Jan/Feb 2016
Pg. 6-10
|
Microbial Identification in Pharmaceutical Compounding
Hyde Tiffany, Anstead James, Schade Lisa, Zellner James
|
Jan/Feb 2016
Pg. 13-18
|
Basic Principles of Lyophilization, Part 2
Akers Michael J
|
Jan/Feb 2016
Pg. 20-27
|
Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success
Pritchett Jon, Mixon William, O'Connell Kevin
|
Jan/Feb 2016
Pg. 29-36
|
Formulation and Stability of Solutions
Akers Michael J
|
Jan/Feb 2016
Pg. 41-45
|
Calculations
Stockton Shelly J
|
Jan/Feb 2016
Pg. 46
|
Aprepitant 80-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 48
|
Aripiprazole 10-mg Oral Dissolving Tablets
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 49
|
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 50
|
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 51
|
Mupirocin Calcium 2% Cream
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 52
|
Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 53
|
Thrombin 1,000 Units/mL Topical Solution, Sterile
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 54
|
Tropicamide 1% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 55
|
Vancomycin 5% and Amikacin 2% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 56
|
Voriconazole 10-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 57
|
Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care
Guimarães Anna Luísa Aguiar, Cunha Elisa Alves, Matias Fernanda Oliveira, Garcia Patrícia Guedes, Danopoulos Panagiota, Swikidisa Rosita, Pinheiro Vanessa Alves, Nogueira Rodrigo José Lupatini
|
Jan/Feb 2016
Pg. 58-62
|
Validation of Ultraviolet-visible and High-performance Liquid Chromatographic Methods for the Determination of Sodium p-Aminosalicylate and m-Aminophenol in a New Pharmaceutical Formulation
Hergert Lisandro Y, Ravetti Soledad, Mazzieri Maria R
|
Jan/Feb 2016
Pg. 63-70
|
A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis
Turner Rob, Weaver Sean, Caserta Francesco, Brown Marc B
|
Jan/Feb 2016
Pg. 71-80
|
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita, Hill Ashley, Killian Alyssa
|
Jan/Feb 2016
Pg. 81-85
|
PostScription: The Home Field Advantage
Cabaleiro Joe
|
Jan/Feb 2016
Pg. 86-87
|
PreScription: Compounding: A Changing Paradigm
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 92
|
Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations
McCrory Gary
|
Mar/Apr 2016
Pg. 95-96
|
Root Cause Analysis, Part 2: Sterile Compounding
Cabaleiro Joe, Jackson Kathleen
|
Mar/Apr 2016
Pg. 99-104
|
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Rabi Joseph
|
Mar/Apr 2016
Pg. 107-113
|
Pharmaceutical Compounding in Portuguese Community Pharmacies: Characterization and Future Perspectives
Palmeira-de-Oliveira Rita, Macedo Marina, Machado Rita M, Pacheco Ana Filipa, Palmeira-de-Oliveira Ana, Martinez-de-Oliveira José, Duarte Paulo
|
Mar/Apr 2016
Pg. 114-122
|
Basics of Compounding: Capsules
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 125-134
|
Formulation and Stability of Solutions
Akers Michael J
|
Mar/Apr 2016
Pg. 137-141
|
Calculations
Stockton Shelly J
|
Mar/Apr 2016
Pg. 142
|
Blue Goo Anti-Itch Gel
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 144
|
Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 145
|
Medicated Polyox Bandage for Skin Ulcers
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 146
|
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 147
|
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
|
Mar/Apr 2016
Pg. 148-154
|
Utilization of Compounded Medications in an Oral Medicine Practice
Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
|
Mar/Apr 2016
Pg. 155-158
|
Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups
Kirk Loren, Lewis Paul, Luu Yao, Brown Stacy
|
Mar/Apr 2016
Pg. 159-163
|
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures
Nahata Milap C
|
Mar/Apr 2016
Pg. 164-166
|
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
|
Mar/Apr 2016
Pg. 167-174
|
PreScription: Patient Access to Pharmaceuticals
Allen Loyd V Jr
|
May/Jun 2016
Pg. 180
|
Current Perspectives on the Syringe Delivery System
Akers Michael J
|
May/Jun 2016
Pg. 182-186
|
Compounding in Nigeria
Alfred-Ugbenbo Deghinmotei, Zdoryk Oleksandr A, Georgiyants Victoriya A, Schnatz Rick
|
May/Jun 2016
Pg. 189-192
|
IACP Names Voliva Executive Vice President
McCrory Gary
|
May/Jun 2016
Pg. 194
|
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Sturn Kayla M, Collin Michael
|
May/Jun 2016
Pg. 197-201
|
Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
|
May/Jun 2016
Pg. 202-206
|
Basics of Compounding: Special Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 209-214
|
Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration
Akers Michael J
|
May/Jun 2016
Pg. 217-222
|
Calculations
Stockton Shelly J
|
May/Jun 2016
Pg. 224
|
Carboplatin 50-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 226
|
Cefotetan Disodium Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 227
|
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Allen Loyd V Jr
|
May/Jun 2016
Pg. 228
|
Dexpanthenol 5% Nasal Spray
Allen Loyd V Jr
|
May/Jun 2016
Pg. 229
|
Indomethacin Gel
Allen Loyd V Jr
|
May/Jun 2016
Pg. 230
|
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
|
May/Jun 2016
Pg. 231
|
Montelukast Sodium 5-mg Fast-Dissolving Film
Allen Loyd V Jr
|
May/Jun 2016
Pg. 232
|
Pain-Away II Headache Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 233
|
Sodium Nitroprusside 25-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 234
|
Zolpidem Tartrate 5-mg and 10-mg Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 235
|
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration
Mody Vicky, Shah Samit, Patel Jaymin, Thomas Michael C
|
May/Jun 2016
Pg. 236-238
|
Topical Metered-dosing Dispenser Performance Evaluation
Liu Qiang, Kupiec Thomas C, Vu Nicole T
|
May/Jun 2016
Pg. 239-246
|
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children
Nahata Milap C
|
May/Jun 2016
Pg. 247-249
|
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Trimble John, Light Bob
|
May/Jun 2016
Pg. 250-256
|
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
|
May/Jun 2016
Pg. 257-261
|
PostScription: Supporting Your Alma Mater: Whose World Will You Change?
Tigelaar Michele
|
May/Jun 2016
Pg. 262-263
|
PreScription: Is the United States Pharmacopeial Convention, Inc., Authorized to Establish "Official" Practice Standards for Pharmacy, Medicine, and Nursing?
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 268
View Sample |
Compounding Transdermal Medication for Feline Patients
Eichstadt Lauren R
|
Jul/Aug 2016
Pg. 271-274
|
Case Report: Pediatric Scar Management After Open-heart Surgery
Phan Ha, Harger Beau, Estrada Nick
|
Jul/Aug 2016
Pg. 277-280
|
Choosing a Vial Processing Line for Aseptic Compounding: Part 1
Noorian Shaun, Vahedi Navid
|
Jul/Aug 2016
Pg. 283-292
|
IACP's 2016 Compounders on Capitol Hill Asks
|
Jul/Aug 2016
Pg. 294-296
|
Basics of Compounding: Compounding Films
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 298-305
|
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding
Akers Michael J
|
Jul/Aug 2016
Pg. 307-314
|
Calculations
Stockton Shelly J
|
Jul/Aug 2016
Pg. 316-317
|
Dolasetron Mesylate 20-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 318
|
Gatifloxacin 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 319
|
Mebendazole 100-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 320
|
Neomycin Sulfate 25-mg/mL Oral Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 321
|
Nystatin 100,000-units Vaginal Inserts
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 322
|
1,2-Octanediol 5% Topical Liquid
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 323
|
Phytonadione 1-mg/mL Oral Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 324
|
Plasmingen and Hyaluronate Sodium Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 325
|
Scopolamine Hydrobromide 0.25% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 326
|
Tretinoin 10-mg Oral Capsules
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 327
|
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
|
Jul/Aug 2016
Pg. 328-332
|
Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations
Lupatini Nogueira Rodrigo José, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa
|
Jul/Aug 2016
Pg. 333-337
|
Stability of Ampicillin in Normal Saline and Buffered Normal Saline
Maher Moureddine, Jensen Kara J, Lee David, Nix David E
|
Jul/Aug 2016
Pg. 338-342
|
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump
Tomasello Cristina, Leggieri Anna, Rabbia Franco, Veglio Franco, Baietto Lorena, Fulcheri Chiara, De Nicolò Amedeo, De Perri Giovanni, D'Avolio Antonio
|
Jul/Aug 2016
Pg. 343-346
|
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product
Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
Jul/Aug 2016
Pg. 347-350
|
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 351
View Sample |
PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 356
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Deleruyelle Laura J
|
Sep/Oct 2016
Pg. 359-364
|
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Kochanowska-Karamyan Anna J
|
Sep/Oct 2016
Pg. 367-374
|
More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard!
Voliva John
|
Sep/Oct 2016
Pg. 377-378
|
Quality Control Analytical Methods: Method Validation
Klang Mark G, Williams LaVonn A
|
Sep/Oct 2016
Pg. 381-386
|
Basics of Compounding: Clinical Pharmaceutics, Part 1
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 389-396
|
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 399-404
|
Calculations
Stockton Shelly J
|
Sep/Oct 2016
Pg. 405
|
Clobazam 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 406
|
Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 407
|
Inamrinone 5-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 408
|
Levetiracetam 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 409
|
Naproxen 5% Cream
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 410
|
Permethrin 1% Lotion
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 411
|
Progesterone 10% Cream
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 412
|
Sodium Phosphate Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 413
|
Tetracaine Hydrochloride 2% Topical Solution
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 414
|
Tromethamine Injection
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 415
|
Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product
Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
Sep/Oct 2016
Pg. 416-420
|
Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt
Pramar Yashoda V, Graves Richard A, Ledet Grace A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K
|
Sep/Oct 2016
Pg. 421-425
|
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions
Polonini Hudson C, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O
|
Sep/Oct 2016
Pg. 426-434
|
Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light
Anderson Collin R, Collins Deborah, Laursen Trevor, Arave Trevor, Helm Michael
|
Sep/Oct 2016
Pg. 435-437
|
A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution
Tannous Elias, Tal Yana, Amarny Kamal
|
Sep/Oct 2016
Pg. 438-439
|
PreScription: Two Decades of IJPC
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 444
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Deleruyelle Laura J
|
Nov/Dec 2016
Pg. 447-454
|
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)
|
Nov/Dec 2016
Pg. 457-458
|
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
|
Nov/Dec 2016
Pg. 461-467
|
Why Become Pharmacy Compounding Accreditation Board Accredited?
Dillon L Rad
|
Nov/Dec 2016
Pg. 469-474
|
The "Lists": What Do They Mean?
Voliva John
|
Nov/Dec 2016
Pg. 477-479
|
Introduction to Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 481-484
|
Basics of Compounding: Clinical Pharmaceutics, Part 2
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 485-493
|
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 495-500
|
Calculations
Stockton Shelly J
|
Nov/Dec 2016
Pg. 502
|
Alendronate 70-mg/75-mL Drinkable Formulation
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 504
|
Bosentan 6.25-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 505
|
Capsaicin 0.025% and Doxepin 3.3% Cream
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 506
|
Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 507
|
Erlotinib 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 508
|
Flumazenil 0.1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 509
|
Imatinib 40-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 510
|
Lapatinib Ditosylate 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 511
|
Melatonin 2-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 512
|
Menthol, Chloral Hydrate, and Camphor Analgesic Ointment
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 513
|
Stability of Fentanyl Citrate in Polyolefin Bags
Donnelly Ronald F
|
Nov/Dec 2016
Pg. 514-516
|
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial
Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
|
Nov/Dec 2016
Pg. 517-520
|
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature
Larson Bayli, Bushman Lane R, Casciano Matthew L, Oldland Alan R, Kiser Jennifer J, Kiser Tyree H
|
Nov/Dec 2016
Pg. 521-525
|
PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution
Rost Erika
|
Nov/Dec 2016
Pg. 526-527
|
Return to Top |